Insider Trading March 23, 2026

Gap CFO Disposes of $278,488 in Stock as Company Reports In-Line Q4 Results

Katrina O'Connell sold 11,503 shares under a 10b5-1 plan; Gap posts Q4 FY2025 EPS of $0.45 and $4.2B revenue amid tariff-related margin pressure

By Leila Farooq GAP
Gap CFO Disposes of $278,488 in Stock as Company Reports In-Line Q4 Results
GAP

Gap Inc.'s chief financial officer, Katrina O'Connell, sold 11,503 shares on March 18, 2026 under a Rule 10b5-1 trading plan, generating $278,488 at a weighted average price of $24.2101. The company reported fourth-quarter fiscal 2025 results that met analysts' expectations, while market reaction was muted amid tariff-related margin concerns. TD Cowen reiterated a Buy rating with a $32 price target.

Key Points

  • CFO Katrina O'Connell sold 11,503 Gap shares on March 18, 2026, for $278,488 at a weighted average of $24.2101; price range $23.75 to $24.42.
  • Gap reported Q4 FY2025 results in line with expectations - EPS $0.45 and revenue $4.2 billion - but market reaction was cautious due to tariff-related margin pressures.
  • TD Cowen reiterated a Buy rating with a $32 price target; Gap updated award agreements under its 2016 Long-Term Incentive Plan to govern future grants.

Katrina O'Connell, Gap Inc.'s chief financial officer, reported a sale of 11,503 shares of common stock on March 18, 2026, according to an amended SEC filing. The shares moved at a weighted average price of $24.2101, producing total proceeds of $278,488, with individual sale prices ranging from $23.75 to $24.42. At the time of the filing the stock was trading at $24.69 and has risen 27% over the past year, while InvestingPro analysis cited in the filing indicates the company may still be undervalued at current levels.

Following the disposition, O'Connell directly holds 8,486 shares of Gap common stock. The transaction was carried out under a Rule 10b5-1 trading plan that she adopted on June 12, 2025. The recent filing is an amendment to a previously submitted report; the sale itself was omitted from the earlier filing because of an administrative error, the amendment states.

Separately, Gap released fourth-quarter results for fiscal 2025 that matched analysts' expectations, reporting earnings per share of $0.45 and revenue of $4.2 billion. Despite meeting consensus forecasts, the market response to the quarterly print was cautious. The filing and associated materials attribute the subdued reception in part to tariff challenges that have pressured margins.

In governance and compensation news, Gap updated award documentation under its 2016 Long-Term Incentive Plan. The company introduced revised forms of its Restricted Stock Unit Award Agreement and other related agreements, which are intended to govern future equity grants to eligible employees and directors.

On the analyst front, TD Cowen reiterated a Buy rating on Gap and maintained a $32.00 price target. In its note, the firm pointed to continued business momentum as a supporting factor despite the fourth-quarter headwinds. TD Cowen highlighted merchandise execution, brand relevance, and strategic marketing as contributors to the company's steady performance.


Contextual note - The SEC amendment documents the insider sale and the company disclosures provide the most recent operational and compensation updates. The combined items - an insider sale executed under a 10b5-1 plan, in-line quarterly results, tariff-related margin pressure, administrative filing correction, and an analyst Buy reiteration - present a snapshot of Gap's current position without suggesting any additional interpretation beyond the filings and announcements.

Risks

  • Tariff challenges affecting margins - impacts retail and consumer discretionary sectors as margins are pressured by external cost factors.
  • Administrative filing errors - raises short-term transparency and compliance concerns for market participants tracking insider activity.
  • Muted market response to in-line earnings - may reflect investor sensitivity to margin headwinds and cost pressures in apparel retail.

More from Insider Trading

Adaptive Biotechnologies President Rubinstein Disposes $769K in Shares, Exercises Options Mar 23, 2026 Director Ault Adds 24,000 Shares to Universal Safety Products Stake in Three Trades Mar 23, 2026 Sprouts VP Sells Shares to Cover Taxes as Analysts Trim Targets Mar 23, 2026 Sprouts CTO Sells 208 Shares to Cover RSU Taxes as Analysts Trim Targets After Q4 Beat Mar 23, 2026 Sprouts CFO Disposes $21,244 in Shares as Analysts Adjust Targets Mar 23, 2026